Related Experiment Video
Updated: Apr 11, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Non-coding RNAs derived from an alternatively spliced REST transcript (REST-003) regulate breast cancer invasiveness
Nan Sook Lee1, Oleg V Evgrafov2, Tade Souaiaia2
11] Physiology &Biophysics and Zilkha Neurogenetic Institute, University of Southern California, Los Angeles [2] Dept of Biomedical Engineering, University of Southern California, Los Angeles.
RE1-Silencing Transcription factor (REST) regulates breast cancer invasiveness through non-coding RNAs, not just gene transcription. Downregulating REST increases invasiveness, while overexpressing it decreases invasiveness, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- RE1-Silencing Transcription factor (REST) is crucial for neuronal gene regulation.
- The role of REST in cancer, particularly breast cancer, is not fully understood.
- REST influences cell invasiveness, but the underlying mechanisms are unclear.
Purpose of the Study:
- To investigate the role of REST in regulating breast cancer cell invasiveness.
- To elucidate the molecular mechanisms by which REST affects cancer cell phenotype.
- To identify potential therapeutic targets for breast cancer metastasis.
Main Methods:
- Utilized MCF-7 and MDA-MB-231 breast cancer cell lines with varying invasiveness.
- Manipulated REST expression levels (downregulation and overexpression).
- Analyzed the role of non-coding RNAs (ncRNAs) derived from the REST-003 transcript and the SRRM3 protein.
Main Results:
- REST downregulation increased invasiveness in MCF-7 cells; REST overexpression decreased invasiveness in MDA-MB-231 cells.
- Phenotypic changes were mediated by mid-size ncRNAs from the REST-003 transcript, not REST's transcriptional activity.
- SRRM3 protein controls the processing of REST-003 into these ncRNAs, and its expression may be REST-regulated.
Conclusions:
- REST influences breast cancer invasiveness via ncRNAs derived from its alternatively spliced transcript.
- SRRM3-mediated processing of REST-derived ncRNAs represents a novel regulatory pathway.
- Targeting these specific ncRNAs offers a potential strategy to combat breast cancer metastasis.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs

